Equities Research Analysts’ price target changes for Tuesday, January 23rd: Bunge Global (NYSE:BG) had its target price cut by Robert W. Baird from $125.00 to $108.00. The firm currently has a neutral rating on the stock. Coherus BioSciences (NASDAQ:CHRS) had its price target trimmed by Robert W. Baird from $11.00 to $9.00. They currently have […]